This systematic review of 9 studies confirms that under-correction of myopia does not slow progression; rather, at least half of the studies have shown the myopia progression is accelerated. There was no benefit found in overcorrection, and the evidence for un-correction was equivocal. Clinically, this advocates for the full correction of myopia.
After the 3-year MiSight 1 day clinical trial, the control group children were switched to MiSight. A ‘virtual control group’ mathematical model, previously published, was utilized to demonstrate a continued myopia control effect across six years, plus effectiveness of treatment for children who commenced wear at age 11-15 years.
This landmark paper examines the theory underlying the reporting of myopia control efficacy and the sequelae of such investigation. The authors propose an alternate method of reporting efficacy; Cumulative Absolute Reduction in Axial Elongation (CARE), which conveys the benefit that a child receiving a specified treatment might expect, independent of age, progression rate, refractive error and ethnicity over a stated time period.
The much anticipated BLINK study has just been published! Hot off the press, we examine the results comparing +1.50 and +2.50 centre distance MFCLs, explain the study and describe how these results compare to other myopia controlling contact lenses.
Can centile growth charts for axial length growth be used to predict success with a myopia control intervention? The three-year MiSight data was modelled against population data as a step towards validated normative data.
Welcome to the final instalment of myopia content from the American Academy of Optometry 2019 meeting. These updates continue from Part 2, which detailed Mark Bullimore and Noel Brennan’s fantastic session entitled Twelve Evidence Based Things That We Should Know About Myopia.
AAO2019 Meeting and third biannual World Congress of Optometry– Addressing the global myopia burden: guest summary by Sally Dillehay.
This GSLS 2020 update compares the risk of vision loss with contact lens wear to vision saved by reducing final myopia.
Welcome to Part 2 of the news update of the 2020 Global Specialty Lens Symposium, held in Las Vegas. Read on for updates on the risk-to-benefit comparison of myopia control, how to talk myopia successfully with parents and how to integrate myopia control into your practice.
The latest from the Global Specialty Lens Symposium 2020 (GSLS2020) on research, intervention updates and young adult myopia progression.
